SIM
TARO

Strategic Investment Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Strategic Investment Management’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,985
Closed -$219K – 146
2016
Q3 		$219K Buy
+1,985
New +$263K 0.16% 65
2015
Q3 		– Sell
-1,603
Closed -$230K – 135
2015
Q2 		$230K Buy
+1,603
New +$229K 0.15% 76

Other funds holding TARO

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Strategic Investment Management's TARO Position: Q4 2016 in Review

Strategic Investment Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2016, closing a stake of 1,985 shares — an estimated $219K sold.

Strategic Investment Management first reported a position in TARO in Q2 2015 and held it in 2 quarters. The position peaked at $230K in Q2 2015. 151 funds tracked by Wall St. Rank hold TARO as of Q4 2016.

  • Strategic Investment Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2016 after selling out during the quarter.
  • Strategic Investment Management sold 1,985 Taro Pharmaceutical Industries Ltd. shares in Q4 2016, an estimated $219K.
  • Strategic Investment Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2015 and held it in 2 quarters.
  • Strategic Investment Management's Taro Pharmaceutical Industries Ltd. position peaked at $230K in Q2 2015.
  • 151 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2016.

Based on Strategic Investment Management's 13F filing for Q4 2016, filed 15 Feb 2017.